<--- Back to Details
First PageDocument Content
Tissues / Signal transduction / Mammalian target of rapamycin / Protein kinases / Immunosuppressants / AKT / Perilipin / Sirolimus / Muscle / Biology / Anatomy / Muscular system
Date: 2015-03-18 09:36:02
Tissues
Signal transduction
Mammalian target of rapamycin
Protein kinases
Immunosuppressants
AKT
Perilipin
Sirolimus
Muscle
Biology
Anatomy
Muscular system

mTORC2 Regulation of Muscle Metabolism and Insulin Sensitivity

Add to Reading List

Source URL: nexs.ku.dk

Download Document from Source Website

File Size: 35,74 KB

Share Document on Facebook

Similar Documents

Pharmacology / Biotechnology / Health care / Recombinant proteins / Pharmaceutical industry / Immunosuppressants / Amgen / Biosimilar / Etanercept / Filgrastim / Hospira / Generic drug

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

DocID: 1rrNB - View Document

Multiple sclerosis / Medicine / Immunology / Clinical medicine / Autoimmune diseases / Neurological disorders / Neurology / Management of multiple sclerosis / Glatiramer acetate / Immunosuppressants / McDonald criteria / Diagnostic criteria for MS

Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

DocID: 1rmwo - View Document

Medicine / Immunosuppressants / Immunology / Clinical medicine / Monoclonal antibodies / Cytokines / Therapeutic antibodies / Autoimmune diseases / Infliximab / Anakinra / Adalimumab / Interferon

EAP Reimbursement Criteria for Frequently Requested Drugs

DocID: 1rhhE - View Document

Medicine / Clinical medicine / Immunology / Immunosuppressants / RTT / Biotechnology / Autoimmune diseases / Arthritis / Certolizumab pegol / TNF inhibitor / UCB / Anakinra

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

DocID: 1rakB - View Document

Medicine / Immunology / Clinical medicine / Health care / Immunosuppressants / Biotechnology / Monoclonal antibodies / Immune system / Immunogenicity / Autoimmunity / Infliximab / Arthritis

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qY7G - View Document